Yvonne Tan from Nuclera shares how a microfluidic-based solution helps scientists tackle membrane protein production challenges head-on.



Summary

Yvonne Tan of Nuclera highlights the difficulties researchers face in producing membrane proteins, essential for drug discovery and understanding cellular processes. She presents Nuclera’s microfluidic technology as a powerful solution to these challenges. This innovative platform enables faster, more efficient, and cost-effective production of high-quality membrane proteins. By automating and optimizing the expression process, Nuclera’s approach empowers scientists to overcome bottlenecks, accelerate research, and unlock the potential of membrane proteins for therapeutic development.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!